Mayne Pharma Group Ltd

Mayne Pharma Group Ltd Stock

14.66P/E
€303.61MMarket capitalisation
A$0.39Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

Mayne Pharma Group Ltd is registered in the following country: Australia (Exchange: AUASX).

Key metrics

Key metrics and master data for the Mayne Pharma Group Ltd stock.

Market capitalisation
€303.61M
P/E
14.66
P/B
1.16
P/S
1.23
P/CF
32.57
Issued shares 82M Units

Return

Here you can see the performance of the Mayne Pharma Group Ltd stock.

PeriodPerfor­mance
1 Week+71.72 %
1 Month+126.67 %
3 Months+98.83 %
6 Months+169.84 %
1 Year+4.94 %
YTD+109.88 %

Dividends

With an (expected) annual dividend of £0.0245, the current stock price results in a dividend yield of —.

Dividend typeSpecial dividend
(Expected) annual dividend £0.0245
Dividend yield —

Splits

The table shows the splits of the Mayne Pharma Group Ltd share.

DateRatio
No data available.

Which ETF contains the Mayne Pharma Group Ltd stock?

The Mayne Pharma Group Ltd stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Mayne Pharma Group Ltd has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Mayne Pharma Group Ltd stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.